Sanofi’s Rilzabrutinib Gets EU Orphan Drug Status for IgG4-Related Disease
Paris, August 14, 2025 – The European Medicines Agency (EMA) has granted orphan drug designation to Sanofi’s rilzabrutinib, a...
Sanofi
Advertisement
Sanofi Strengthens Vaccine Pipeline with Acquisition of Vicebio
Paris, France — August 21, 2025 – Sanofi has announced the acquisition of Vicebio, a biotechnology company specializing in...
Advertisement
